Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does estrogen stimulate osteoblast function in postmenopausal women?

J H Tobias1, J E Compston

  • 1Rheumatology Unit, University of Bristol Division of Medicine, Bristol Royal Infirmary, UK. Jon.Tobias@bris.ac.uk

Bone
|February 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive descriptive analysis of hip and knee radiographic osteoarthritis in the UK Biobank in relation to joint pain, joint site interrelationships, obesity, race and deprivation: Findings from 59,475 individuals.

medRxiv : the preprint server for health sciences·2026
Same author

Associations between work characteristics and osteoarthritis: A cross-sectional study of 285,947 UK Biobank participants.

Osteoarthritis and cartilage open·2025
Same author

Cardiovascular risk assessment for osteoporosis patients considering Romosozumab.

Bone·2024
Same author

Hip geometric parameters are associated with radiographic and clinical hip osteoarthritis: Findings from a cross-sectional study in UK Biobank.

Osteoarthritis and cartilage·2023
Same author

Editorial: The "GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork" (GEMSTONE).

Frontiers in endocrinology·2023
Same author

High bone mass and cam morphology are independently related to hip osteoarthritis: findings from the High Bone Mass cohort.

BMC musculoskeletal disorders·2022
Same journal

Baseline β-CTX and BMI predict suitability for deferred zoledronic acid redosing beyond 12 months in postmenopausal Indian women with osteoporosis.

Bone·2026
Same journal

Bone density-based maturation of the midpalatal suture in children aged 8-15 years.

Bone·2026
Same journal

Disrupted phosphate metabolism and SIBLING/ASARM peptide accumulation underlie impaired bone mineralization in klotho-deficient (kl/kl) mice.

Bone·2026
Same journal

Linking genetic variants to bone microstructure: Histological signatures of osteogenesis imperfecta subtypes.

Bone·2026
Same journal

The impact of alcohol consumption on bone mineral density: Insights from cross-sectional and Mendelian randomization studies.

Bone·2026
Same journal

Systemic and local predictors of medication-related osteonecrosis of the jaw in patients receiving antiresorptive therapy: The Shizuoka Kokuho Database study.

Bone·2026
See all related articles

Estrogen therapy in postmenopausal women primarily reduces bone loss by suppressing resorption. However, high estrogen levels may also stimulate bone formation by enhancing osteoblast activity, offering new treatment possibilities for osteoporosis.

Area of Science:

  • Endocrinology
  • Bone Biology
  • Postmenopausal Health

Background:

  • Estrogen therapy is used to manage bone loss in postmenopausal women.
  • Conventional estrogen doses mainly inhibit bone resorption.
  • Previous studies showed limited evidence for estrogen stimulating bone formation.

Purpose of the Study:

  • To investigate the influence of estrogen therapy on bone metabolism in postmenopausal women.
  • To explore the potential stimulatory effect of high estrogen levels on osteoblast function.
  • To assess the implications for developing new osteoporosis treatments.

Main Methods:

  • Review of existing studies using bone densitometry, biochemical markers of bone turnover, and histomorphometry.
  • Analysis of findings from patients treated with estradiol implants.

Related Experiment Videos

  • Synthesis of evidence on estrogen's role in regulating osteoblast activity.

    • Main Results:

    • Conventional estrogen doses primarily suppress bone resorption, limiting bone loss.
    • Prolonged exposure to high estrogen levels, via implants, demonstrated a stimulatory effect on osteoblast function.
    • Estrogen is confirmed as a physiological regulator of osteoblast activity.

    Conclusions:

    • Estrogen therapy can influence bone metabolism through both resorption inhibition and potentially bone formation stimulation.
    • High-dose or prolonged estrogen exposure may enhance osteoblast activity in postmenopausal women.
    • Developing strategies that mimic high estrogen levels could offer novel therapeutic approaches for postmenopausal osteoporosis.